Back to announcement
20251027_BMHS_Laporan Informasi dan Fakta Material_31979737_lamp1.pdf
Other Text extracted BMHSSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.905
($ bmhs
2)
since 1973
No. :597-K/PD/BMHS/X/2025
Lampiran/Attachment
Perihal /In Reference
II Window Exercise II Tahun 2
Jakarta, 27 Oktober 2025
: Informasi Rencana Periode Pelaksanaan Tahap I Window Exercise II dan Tahap
025 Program Management and Employee Stock
Option Program (MESOP) PT Bundamedik Tbk / Information on Planned
Implementation Period of Phase I Window Exercise II and Phase II Window
Exercise II of 2025 Program Management and Employee Stock Option Program
(MESOP) of PT Bundamedik Tbk
Kepada Yth./To:
1.
Otoritas Jasa Keuangan ("OJK")/ Financial Services Authority ("OJK")
Gedung Sumitro Djojohadikusumo/ Sumitro Djojohadikusumo Building
JI. Lapangan Banteng Timur No. 2-4 Jakarta - 10710
Attn./U.p.: Kepala Eksekutif Pengawas Pasar Modal/ Executive Head of Capital Market Supervisory
. PT Bursa Efek Indonesia ("BEI")/ Indonesia Stock Exchange ("IDX")
Gedung Bursa Efek Indonesia Tower 1, Lantai 4 Jend. Sudirman Kav. 52-53 Jakarta -12190
Attn./U.p.: Direktur Penilaian Perusahaan/ Director
Dengan hormat,
Merujuk kepada Pasal 43A Peraturan Otoritas Jasa
Keuangan No. 32/POJK.04/2015 tentang
Penambahan Modal Perusahaan Terbuka Dengan
Memberikan Hak Memesan Efek Terlebih Dahulu
(sebagaimana diubah dengan Peraturan Otoritas
Jasa Keuangan No. 14/POJK.04/2019) dan Surat
Edaran PT Bursa Efek Indonesia Nomor SE-
00002/BEI/03- 2020 tanggal 2 Maret 2020 perihal
Tata Cara Pelaksanaan Program Kepemilikan Saham,
bersama ini kami sampaikan keterbukaan informasi
sehubungan pelaksanaan — Program
Kepemilikan Saham Perseroan sebagai berikut:
dengan
of Corporate Valuation
Dear Sirs,
Referring to Article 43A of Financial Services
Authority Regulation — No. 32/POJK.04/2015
concerning Capital Increase for Public Companies
by Providing Pre-emptive Rights (as amended by
Financial Services Authority Regulation No.
14/POJK.04/2019) and PT Bursa Efek Indonesia
Circular Letter Number SE-00002/BE1/03-2020
dated March 2”3, 2020 regarding the Procedures
for Implementing the Share Ownership Program,
we hereby submit information disclosure regarding
the implementation of the Company's Share
Ownership Program as follows:
No. Keterangan/Description Penjelasan/Explanation
1. Periode Pelaksanaan Tahap | Window Exercise | 30 (tiga puluh) hari bursa terhitung sejak
Il dan Tahap II Window Exercise II/ tanggal 1 November 2025 sampai dengan
Implementation Period of Phase I Window | tanggal 12 Desember 2025/ 30 (thirty) trading
Exercise II and Phase II Window Exercise II days from November 1", 2025 to December 12",
2025.
2. Harga Pelaksanaan Tahap | Window Exercise II | Rp. 863 per lembar/IDR 863 per shares
yang Telah Ditetapkan Sebelumnya/ Pre-Set
Execution Price of Phase I Window Exercise II
Because Zansily/Malters
PT Bundamedik Tbk
Jl. Teuku Cik Ditiro No. 28, Menteng - Jakarta Pusat 10350, Indonesia
Head Office: BMHS Diagnos Tower 6" - 7" Floor
Jl. Teuku Cik Ditiro No. 11, Menteng -Jakarta Pusat 10350, Indonesia
www.bmhs.co.id @ 021-50980799 @
».
Be AAA. A
Page 2 OCR 0.912
G bmhs since 1973 Harga Pelaksanaan Tahap II Window Exercise II/ Pre-Set Execution Price of Phase II Window Exercise II Rp. 363 per lembar/ IDR 363 per shares Jumlah Hak Opsi yang Dikonversi Untuk Periode Pelaksanaan Tahap I Window Exercise II/ Number of Option Rights Converted For This Execution Period of Phase I Window Exercise II Jumlah Hak Opsi yang Dikonversi untuk Periode Pelaksanaan sebanyak-banyaknya 22.500.000 saham dan Hak Opsi yang belum Dikonversi pada Periode Pelaksanaan ini dapat dilakukan pada periode pelaksanaan berikutnya/ The maximum number of Converted Option Rights for the Implementation Period is 22,500,000 shares and the Option Rights that have not been converted in this Implementation Period can be exercised in the next implementation period. 5. | Jumlah Hak Opsi yang Dikonversi Untuk | Jumlah Hak Opsi yang Dikonversi untuk Periode Periode Pelaksanaan Tahap Il Window | Pelaksanaan sebanyak-banyaknya 2.500.000 Exercise II/ Number of Option Rights | saham dan Hak Opsi yang belum Dikonversi Converted For This Execution Period of Phase II Window Exercise II pada Periode Pelaksanaan ini dapat dilakukan pada periode pelaksanaan berikutnya/ The maximum number of Converted Option Rights for the Implementation Period is 2,500,000 shares and the Option Rights that have not been converted in this Implementation Period can be exercised in the next implementation period. Demikian surat ini kami sampaikan. Atas perhatian dan kerjasamanya, kami ucapkan terima kasih. Hereby we convey this letter. Thank you for your attention and cooperation. Hormat kami/Regards, PT Bundamedik Tbk Agus Heru Darjono $' President Director PT Bundamedik Tbk Jl. Teuku Cik Ditiro No. 28, Menteng - Jakarta Pusat 10350, Indonesia Head Office: BMHS Diagnos Tower 6" -7" Floor Jl. Teuku Cik Ditiro No. 11, Menteng - Jakarta Pusat 10350, Indonesia Because Zamuly /Vahe F £5 www.bmhs.co.id @ 021-50980799 @
Names mentioned 8 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Financial Services Authority
p.1 ×3
unresolved
org
Indonesia Stock Exchange
p.1
unresolved
org
PT Bursa Efek Indonesia Circular Letter Number SE-
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.